Drug archive
Infliximab (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Inflammatory bowel disease therapy agent
- antirheumatic agent
Description
Infliximab (in-FLIX-i-mab) is a monoclonal antibody. It is used to treat Crohn's disease in patients who have not been helped by other medicines and also in patients who have a type of Crohn's disease in which fistulas form. It is also used to treat rheumatoid arthritis.
This medicine is available only with your doctor's prescription, in the following dosage form:
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Remicade
Another commonly used name is cA2 .
† Not commercially available in Canada.